Background: There are few data on the prevalence of WHO transmitted drug resistance mutations (TDRs) that could affect treatment responses to first line antiretroviral therapy (ART) in Hunan Province, China. Objective: Determine the prevalence of WHO NRTI/NNRTI/PI TDRs in ART-naive subjects in Hunan Province by deep sequencing. Methods: ART-naive subjects diagnosed in Hunan between 2010-2011 were evaluated by deep sequencing for low-frequency HIV variants possessing WHO TDRs to 1% levels. Mutations were scored using the HIVdb.stanford.edu algorithm to infer drug susceptibility. Results: Deep sequencing was performed on samples from 90 ART-naive subjects; 83.3% were AE subtype. All subjects had advanced disease (average CD4 count 134 cells/mm(3)). Overall 25.6%(23/90) of subjects had HIV with major WHO NRTI/NNRTI TDRs by deep sequencing at a variant frequency level >= 1%; 16.7%(15/90) had NRTI TDR and 12.2%(11/90) had a major NNRTI TDR. The majority of NRTI/NNRTI mutations were identified at variant levels <5%. Mutations were analyzed by HIVdb.stanford.edu and 7.8% of subjects had variants with high-level nevirapine resistance; 4.4% had high-level NRTI resistance. Deep sequencing identified 24(27.6%) subjects with variants possessing either a PI TDR or hivdb.stanford.edu PI mutation (algorithm value >= 15). 17(19.5%) had PI TDRs at levels >1%. Conclusions: ART-naive subjects from Hunan Province China infected predominantly with subtype AE frequently possessed HIV variants with WHO NRTI/NNRTI TDRs by deep sequencing that would affect the first line ART used in the region. Specific mutations conferring nevirapine high-level resistance were identified in 7.8% of subjects. The majority of TDRs detected were at variant levels <5% likely due to subjects having advanced chronic disease at the time of testing. PI TDRs were identified frequently, but were found in isolation and at low variant frequency. As PI/r use is infrequent in Hunan, the existence of PI mutations likely represent AE subtype natural polymorphism at low variant level frequency.
机构:
Bristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
Yale Univ, Sch Med & Vet Affairs Connecticut Healthcare Syst, New Haven, CT USABristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
Lataillade, Max
Chiarella, Jennifer
论文数: 0引用数: 0
h-index: 0
机构:Bristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
Chiarella, Jennifer
Yang, Rong
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USABristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
Yang, Rong
Schnittman, Steven
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USABristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
Schnittman, Steven
Wirtz, Victoria
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USABristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
Wirtz, Victoria
Uy, Jonathan
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USABristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
Uy, Jonathan
Seekins, Daniel
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USABristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
Seekins, Daniel
Krystal, Mark
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USABristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
Krystal, Mark
Mancini, Marco
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USABristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
Mancini, Marco
McGrath, Donnie
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USABristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
McGrath, Donnie
Simen, Birgitte
论文数: 0引用数: 0
h-index: 0
机构:
454 Life Sci, Branford, CT USABristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
Simen, Birgitte
Egholm, Michael
论文数: 0引用数: 0
h-index: 0
机构:
454 Life Sci, Branford, CT USABristol Myers Squibb Co, Global Dev & Med Affairs, Wallingford, CT 06492 USA
机构:
Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USAUniv N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
Yanik, E. L.
Napravnik, S.
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USAUniv N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
Napravnik, S.
Hurt, C. B.
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USAUniv N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
Hurt, C. B.
Dennis, A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USAUniv N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
Dennis, A.
Kuruc, J. D.
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USAUniv N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA
Kuruc, J. D.
Eron, J. J.
论文数: 0引用数: 0
h-index: 0
机构:
Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USAUniv N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA